company

RE BIOCONSULT AS

3174 REVETAL

Return on Equity
96,72 %
Current Ratio
4,59
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 332 000
Net Income885 000
Total Assets1 171 000
Total Equity915 000
Income (NOK)2022
Revenue1 332 000
Expenditure199 000
Operating Profit1 133 000
Financial Income3 000
Financial Costs0
Financial Balance3 000
Earnings Before Tax1 135 000
Tax250 000
Net Income885 000
Balance (NOK)2022
Total Fixed Assets1 000
Total Current Assets1 170 000
Total Assets1 171 000
Total Retained Equity894 000
Total Equity915 000
Total Long-Term Debt0
Total Current Debt255 000
Total Equity and Debt1 171 000
Cash flow (NOK)2022
Sales Income1 332 000
Other Income0
Revenue1 332 000
Cost of Goods Sold125 000
Salary Costs0
Depreciation0
Impairment0
Expenditure199 000
Operating Profit1 133 000
Financial Income3 000
Financial Costs0
Financial Balance3 000
Dividends0
Net Income885 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets1 000
Total Fixed Assets1 000
Stock0
Total Investments0
Cash, Bank1 119 000
Total Current Assets1 170 000
Total Assets1 171 000
Total Equity915 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors4 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt255 000
Total Equity and Debt1 171 000
Financial indicators2022
Return on Equity96,72 %
Debt-to-Equity Ratio0
Operating Profit Margin85,06 %
Current Ratio4,59
Quick Ratio4,59
Equity Ratio0,78
Gross Profit Margin90,62 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English